Amorolfine in the treatment of onychomycoses and dermatomycoses (an overview).
Zaug
M
M
Clinical Research Department, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
Bergstraesser
M
M
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000935:Antifungal Agents / Q000627:therapeutic use*; D003881:Dermatomycoses / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009025:Morpholines / Q000627:therapeutic use*; D014009:Onychomycosis / Q000188:drug therapy*; D011897:Random Allocation; D016896:Treatment Outcome
D000935:Antifungal Agents; D009025:Morpholines; C038974:amorolfine